上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2014年
17期
34-37
,共4页
俞春娟%和明丽%王俊军%丁奇龙
俞春娟%和明麗%王俊軍%丁奇龍
유춘연%화명려%왕준군%정기룡
慢性阻塞性肺疾病急性加重期%低T3综合征%甲状腺功能
慢性阻塞性肺疾病急性加重期%低T3綜閤徵%甲狀腺功能
만성조새성폐질병급성가중기%저T3종합정%갑상선공능
acute exacerbations of chronic obstructive pulmonary disease%low T3 syndrome%thyroid hormones
目的:了解低T3综合征在慢性阻塞性肺疾病急性加重患者中的发生情况及其与疾病严重程度的相关性和预后的关系。方法:选取AECOPD患者152例,根据动脉血气及临床表现分为无呼吸衰竭和右心功能衰竭组(A组)54例、有呼吸衰竭无右心功能衰竭组(B组)42例、无呼吸衰竭有右心功能衰竭组(C组)31例、有呼吸衰竭及右心功能衰竭组(D组)25例。应用化学发光法测定各组血清甲状腺激素水平。结果:低T3综合征发病率为18.42%;通过分类比较,B、C组分别和A组相比,D组分别与A组、B组、C组相比,TT3、FT3下降,差异有统计学意义;合并呼吸衰竭者(B组、D组,67例)较未合并呼吸衰竭者(A组、C组,85例)TT3、FT3下降,差异有统计学意义;152例患者,死亡9例,病情恶化自动出院12例,其余患者(131例)好转出院,与好转出院者相比,死亡组与自动出院组TT3、FT3下降,差异有统计学意义。以上所有比较结果TT4、FT4、TSH差异无统计学意义。结论:血清甲状腺激素水平在AECOPD患者中有不同程度的下降,监测甲状腺功能有助于判断AECOPD患者的病情危重程度及预测预后。
目的:瞭解低T3綜閤徵在慢性阻塞性肺疾病急性加重患者中的髮生情況及其與疾病嚴重程度的相關性和預後的關繫。方法:選取AECOPD患者152例,根據動脈血氣及臨床錶現分為無呼吸衰竭和右心功能衰竭組(A組)54例、有呼吸衰竭無右心功能衰竭組(B組)42例、無呼吸衰竭有右心功能衰竭組(C組)31例、有呼吸衰竭及右心功能衰竭組(D組)25例。應用化學髮光法測定各組血清甲狀腺激素水平。結果:低T3綜閤徵髮病率為18.42%;通過分類比較,B、C組分彆和A組相比,D組分彆與A組、B組、C組相比,TT3、FT3下降,差異有統計學意義;閤併呼吸衰竭者(B組、D組,67例)較未閤併呼吸衰竭者(A組、C組,85例)TT3、FT3下降,差異有統計學意義;152例患者,死亡9例,病情噁化自動齣院12例,其餘患者(131例)好轉齣院,與好轉齣院者相比,死亡組與自動齣院組TT3、FT3下降,差異有統計學意義。以上所有比較結果TT4、FT4、TSH差異無統計學意義。結論:血清甲狀腺激素水平在AECOPD患者中有不同程度的下降,鑑測甲狀腺功能有助于判斷AECOPD患者的病情危重程度及預測預後。
목적:료해저T3종합정재만성조새성폐질병급성가중환자중적발생정황급기여질병엄중정도적상관성화예후적관계。방법:선취AECOPD환자152례,근거동맥혈기급림상표현분위무호흡쇠갈화우심공능쇠갈조(A조)54례、유호흡쇠갈무우심공능쇠갈조(B조)42례、무호흡쇠갈유우심공능쇠갈조(C조)31례、유호흡쇠갈급우심공능쇠갈조(D조)25례。응용화학발광법측정각조혈청갑상선격소수평。결과:저T3종합정발병솔위18.42%;통과분류비교,B、C조분별화A조상비,D조분별여A조、B조、C조상비,TT3、FT3하강,차이유통계학의의;합병호흡쇠갈자(B조、D조,67례)교미합병호흡쇠갈자(A조、C조,85례)TT3、FT3하강,차이유통계학의의;152례환자,사망9례,병정악화자동출원12례,기여환자(131례)호전출원,여호전출원자상비,사망조여자동출원조TT3、FT3하강,차이유통계학의의。이상소유비교결과TT4、FT4、TSH차이무통계학의의。결론:혈청갑상선격소수평재AECOPD환자중유불동정도적하강,감측갑상선공능유조우판단AECOPD환자적병정위중정도급예측예후。
Objective: To study the relationship of disease severity and prognosis between low T3 syndrome and acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Methods:One hundred and iffty-two patients with AECOPD were divided into 4 groups based on their arterial blood partial oxygen pressure/carbon dioxide pressure and clinical manifestation:group A without respiratory failure and right heart failure (n=54);group B with respiratory failure but without right heart failure (n=42);group C with right heart failure but without respiratory failure (n=31);group D with respiratory failure and right heart failure (n=25). Serum levels of thyroid hormones were measured by chemiluminescence method. Results:The morbidity of low T3 syndrome was 18.42%. In group B and group C, levels of TT3, FT3 were signiifcantly lower than those in group A. In group D, serum levels of TT3, FT3 were signiifcantly lower than those in the other three groups. The serum levels of TT3, FT3 were signiifcantly lower in 67 cases with respiratory failure than in 85 cases without respiratory failure. Nine patients died, and 12 patients were discharged themselves and the others were improved. In died and discharged themselves groups, serum levels of TT3, FT3 were signiifcantly lower than those in the improved subgroup. All the comparisons of TT4, FT4 and TSH were not statistically signiifcant. Conclusion:Serum levels of thyroid hormone have different degrees of decline in patients with AECOPD. Monitoring of serum levels of thyroid hormones may be useful in predicting disease severity and outcome for patients with COPD.